Overview
Andrew Schultz is a primary care provider, practicing in Internal Medicine in Windham, New Hampshire. Dr. Schultz is rated as an Experienced provider by MediFind in the treatment of Hemochromatosis. His top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and High Cholesterol.
His clinical research consists of co-authoring 4 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- MANAGED MEDICAID PLAN
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
49 Range Rd, Suite 100, Windham, NH 03087
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Jeralyn Cremone is a primary care provider, practicing in Internal Medicine in West Roxbury, Massachusetts. Dr. Cremone is rated as an Advanced provider by MediFind in the treatment of Hemochromatosis. Her top areas of expertise are Hemochromatosis, Cirrhosis, Polymyalgia Rheumatica, and Rhizomelic Pseudopolyarthritis. Dr. Cremone is currently accepting new patients.
Beth Israel Lahey Health Primary Care, Inc
Armen Arslanian is a primary care provider, practicing in Geriatrics and Internal Medicine in South Hamilton, Massachusetts. Dr. Arslanian is rated as an Advanced provider by MediFind in the treatment of Hemochromatosis. His top areas of expertise are Hemochromatosis, Lung Cancer, Anemia, and Necrosis. Dr. Arslanian is currently accepting new patients.
Hallmark Health Medical Associates Inc
John Mudrock is a primary care provider, practicing in Internal Medicine in Wakefield, Massachusetts. Dr. Mudrock is rated as an Advanced provider by MediFind in the treatment of Hemochromatosis. His top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Type 2 Diabetes (T2D), and Hemochromatosis. Dr. Mudrock is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AsthmaDr. Schultz isExperienced. Learn about Asthma.
- Asthma in ChildrenDr. Schultz isExperienced. Learn about Asthma in Children.
- Attention Deficit Hyperactivity Disorder (ADHD)
- BronchitisDr. Schultz isExperienced. Learn about Bronchitis.
- CellulitisDr. Schultz isExperienced. Learn about Cellulitis.
- Chronic Obstructive Pulmonary Disease (COPD)